A precision approach to probiotics could address the heterogeneity inherent to probiotic strains, the hosts and their microbiomes. Here, we discuss the steps required to develop precision probiotics: mechanistic studies, phenotypic and target-based discovery strategies, and person-centric trials.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A novel infant microbiome formula (SIM03) improved eczema severity and quality of life in preschool children
Scientific Reports Open Access 07 February 2024
-
A probiotic bi-functional peptidoglycan hydrolase sheds NOD2 ligands to regulate gut homeostasis in female mice
Nature Communications Open Access 07 June 2023
-
Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms
npj Biofilms and Microbiomes Open Access 21 January 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Toole, P. W., Marchesi, J. R. & Hill, C. Nat. Microbiol. 2, 17057 (2017).
Suez, J., Zmora, N., Segal, E. & Elinav, E. Nat. Med. 25, 716–729 (2019).
Sniffen, J. C., McFarland, L. V., Evans, C. T. & Goldstein, E. J. C. PLoS ONE 13, e0209205 (2018).
Tannock, G. W. et al. Appl. Environ. Microbiol. 66, 2578–2588 (2000).
Maldonado-Gomez, M. X. et al. Cell Host Microbe 20, 515–526 (2016).
Zhang, C. et al. ISME J. 10, 2235–2245 (2016).
Guyonnet, D., Schlumberger, A., Mhamdi, L., Jakob, S. & Chassany, O. Br. J. Nutr. 102, 1654–1662 (2009).
Zmora, N. et al. Cell 174, 1388–1405 (2018).
Swinney, D. C. Clin. Pharmacol. Ther. 93, 299–301 (2013).
Kelly, J. R. et al. Brain Behav. Immun. 61, 50–59 (2017).
Lucas, N. et al. Microorganisms 8, E35 (2019).
TargEDys. Study to evaluate benefit of ProbioSatys on weight reduction in overweight subjects. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03657186 (2018).
Suez, J. et al. Cell 174, 1406–1423 (2018).
Schork, N. J. Nature 520, 609–611 (2015).
Rashkin, M. D. et al. J. Genet. Couns. 28, 456–465 (2019).
Acknowledgements
We thank the members of the Elinav laboratory and members of the DKFZ Cancer-Microbiome division for discussions. We apologize to authors whose work was not included due to space constraints. We also thank L. Jimenez, S. Miret-Catalan and D. Obis (members of Danone Nutricia Research) for the discussions. E.E. is supported by: Y. and R. Ungar; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; the Leona M. and Harry B. Helmsley Charitable Trust; the Crown Endowment Fund for Immunological Research; the Else Kroener Fresenius Foundation; the estate of J. Gitlitz; the estate of L. Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; the Adelis Foundation; J. L. and V. Schwartz; A. and G. Markovitz; A. and C. Adelson; the French National Center for Scientific Research (CNRS); D. L. Schwarz; the V. R. Schwartz Research Fellow Chair; L. Steinberg; J. N. Halpern; A. Edelheit; and by grants funded by the European Research Council, the Israel Science Foundation and the Helmholtz Foundation. E.E. is the Sir Marc & Lady Tania Feldmann Professorial Chair in Immunology at the Weizmann Institute of Science, the Director of the Microbiome Research Division at DKFZ, is a senior fellow of the Canadian Institute of Advanced Research (CIFAR) and an international scholar of the Bill & Melinda Gates Foundation and Howard Hughes Medical Institute (HHMI).
Author information
Authors and Affiliations
Contributions
P.V., M.D., J.S. and E.E. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
P.V. and M.D. are Danone Nutricia Research employees. E.E. is a paid consultant at DayTwo and BiomX. None of this work is related to, shared with or licensed to these companies or any other commercial entity. The remaining author declares no competing interests.
Rights and permissions
About this article
Cite this article
Veiga, P., Suez, J., Derrien, M. et al. Moving from probiotics to precision probiotics. Nat Microbiol 5, 878–880 (2020). https://doi.org/10.1038/s41564-020-0721-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-020-0721-1
This article is cited by
-
Utilization of the microbiome in personalized medicine
Nature Reviews Microbiology (2024)
-
A novel infant microbiome formula (SIM03) improved eczema severity and quality of life in preschool children
Scientific Reports (2024)
-
Oral Biofilm Composition, Dissemination to Keratinocytes, and Inflammatory Attenuation Depend on Probiotic and Synbiotic Strain Specificity
Probiotics and Antimicrobial Proteins (2024)
-
Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms
npj Biofilms and Microbiomes (2023)
-
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Nature Reviews Clinical Oncology (2023)